Antimicrobial peptides as promising drugs for treatment of primary viral pneumonia
The COVID-19 pandemic which began in March 2020 has again drawn attention to the problem of treating primary viral pneumonia (PVP), wherein damage to the tissues of the lower respiratory tract including functionally important alveolocytes occurs as a result of cell infection by pathogens of the Vira...
Guardado en:
Autores principales: | M. Yu. Shchelkanov, A. V. Cybulsky, V. G. Dedkov, I. V. Galkina, V. V. Maleev |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/edfbbf9c547a4ae99b487a065c38211f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MUCOSAL MICROFLORA AND INNATE IMMUNITY OF UPPER RESPIRATORY TRACT IN INTRAUTERINE FOETAL INFECTION AND PNEUMONIA OF NEONATES
por: O. A. Svitich, et al.
Publicado: (2016) -
ASSOCIATION OF TLR2, TLR4, TLR9 GENE EXPRESSION RELATED TO INNATE IMMUNITY WITH IN VIVO ACUTE RESPIRATORY INFECTIONS CAUSED BY KLEBSIELLA PNEUMONIAE
por: E. V. Budanova, et al.
Publicado: (2018) -
Etiología viral en la neumonía del adulto adquirida en la comunidad en un hospital del sur de Chile
por: Rioseco Z,M. Luisa, et al.
Publicado: (2012) -
Post‐coronavirus disease 2019 organizing pneumonia confirmed pathologically by video‐assisted thoracoscopic surgery
por: Keishi Sugino, et al.
Publicado: (2021) -
Differential Diagnosis between Coronavirus Disease 2019 and Interstitial Pneumonia
por: PENG Min, et al.
Publicado: (2020)